Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Giovanni Martinotti, Bernardo Dell"Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d"Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filippis, Giuseppe Nicolò, Pasquale De Fazio, Ileana Andriola, Raffaella Zanardi, Domenica Nucifora, Stefania Di MauroRoberta Bassetti, Mauro Pettorruso, Roger S McIntyre, Stefano L Sensi, Massimo di Giannantonio, Antonio Vita, REAL-ESK Study Group

    Research output: Contribution to journalOriginal Articlepeer-review

    55 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)233-244
    Number of pages12
    JournalBIPOLAR DISORDERS
    Volume25
    Issue number3
    DOIs
    Publication statusPublished - May 2023

    Keywords

    • INTRAVENOUS KETAMINE
    • DOUBLE-BLIND
    • DISORDER
    • ANXIETY
    • ANTIDEPRESSANT
    • REMISSION
    • Ketamine/therapeutic use
    • Depressive Disorder, Treatment-Resistant/drug therapy
    • Humans
    • Antidepressive Agents/therapeutic use
    • Bipolar Disorder/drug therapy
    • Depression

    Cite this